Vera Therapeutics (VERA) Reiterated at Overweight by Cantor Fitzgerald Jan 16, 2026 06:54AM
Vera Therapeutics prices $261 million stock offering at $42.50 per share Dec 9, 2025 08:57PM
Vera Therapeutics Announces Pricing of Public Offering of Class A Common Stock Dec 9, 2025 08:57PM
Vera Therapeutics' (VERA) Shares Are Still Undervalued - Cantor Fitzgerald Nov 26, 2025 07:05AM
Cantor Fitzgerald Reiterates Overweight on Vera Therapeutics (VERA); Says Shares Undervalued Oct 13, 2025 07:17AM


May 29, 2025 07:59AM Cantor Fitzgerald Reiterates Overweight Rating on Vera Therapeutics (VERA)
May 23, 2025 06:49AM Cantor Fitzgerald Reiterates Overweight Rating on Vera Therapeutics (VERA)
Apr 2, 2025 07:04AM Smid cap biotech investors must stop chasing binary events says Cantor Fitzgerald
Feb 18, 2025 06:46AM Cantor Fitzgerald Reiterates Overweight Rating on Vera Therapeutics (VERA)
Oct 29, 2024 06:04AM Vera Therapeutics Inc. (VERA) Announces Proposed $300M Share Offering
Oct 28, 2024 05:37PM Vera Therapeutics Announces Proposed Public Offering of Class A Common Stock
Jan 8, 2024 06:33AM Cantor Fitzgerald Starts Vera Therapeutics (VERA) at Overweight, 'BAFFling B Cells as APRIL is Fooled'